BIOTON S.A. (BIO.WA)
PLN 2.98
(-0.83%)
PLN 2.98
(-0.83%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 12.67 Million PLN | -32.05% |
| 2022 | 18.65 Million PLN | -36.67% |
| 2021 | 29.45 Million PLN | -24.12% |
| 2020 | 38.82 Million PLN | -18.82% |
| 2019 | 47.82 Million PLN | 169.87% |
| 2018 | 17.72 Million PLN | -24.37% |
| 2017 | 23.43 Million PLN | -50.68% |
| 2016 | 47.5 Million PLN | -26.8% |
| 2015 | 64.9 Million PLN | -33.6% |
| 2014 | 97.75 Million PLN | -12.86% |
| 2013 | 112.18 Million PLN | 573.22% |
| 2012 | 16.66 Million PLN | -86.78% |
| 2011 | 126.05 Million PLN | 9.14% |
| 2010 | 115.49 Million PLN | 464.02% |
| 2009 | 20.47 Million PLN | -87.51% |
| 2008 | 163.89 Million PLN | 0.02% |
| 2007 | 163.86 Million PLN | 2050.22% |
| 2006 | 7.62 Million PLN | 20497.3% |
| 2005 | 37 Thousand PLN | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 15.39 Million PLN | -100.0% |
| 2024 Q1 | 323 Thousand PLN | -81.02% |
| 2023 FY | 12.67 Million PLN | -32.05% |
| 2023 Q1 | 17.28 Million PLN | -7.35% |
| 2023 Q3 | 14.84 Million PLN | -1.03% |
| 2023 Q2 | 15 Million PLN | -13.2% |
| 2023 Q4 | 12.67 Million PLN | -14.62% |
| 2022 Q2 | 21.98 Million PLN | -6.56% |
| 2022 Q1 | 23.52 Million PLN | -20.15% |
| 2022 FY | 18.65 Million PLN | -36.67% |
| 2022 Q4 | 18.65 Million PLN | -8.73% |
| 2022 Q3 | 20.43 Million PLN | -7.01% |
| 2021 FY | 29.45 Million PLN | -24.12% |
| 2021 Q2 | 52.37 Million PLN | 50.95% |
| 2021 Q1 | 34.69 Million PLN | -10.63% |
| 2021 Q3 | 46.35 Million PLN | -11.49% |
| 2021 Q4 | 29.45 Million PLN | -36.45% |
| 2020 FY | 38.82 Million PLN | -18.82% |
| 2020 Q2 | 74.4 Million PLN | -6.76% |
| 2020 Q3 | 69.71 Million PLN | -6.3% |
| 2020 Q4 | 38.82 Million PLN | -44.31% |
| 2020 Q1 | 79.8 Million PLN | 66.87% |
| 2019 FY | 47.82 Million PLN | 169.87% |
| 2019 Q1 | 65.66 Million PLN | 270.54% |
| 2019 Q2 | 60.76 Million PLN | -7.47% |
| 2019 Q3 | 57.37 Million PLN | -5.58% |
| 2019 Q4 | 47.82 Million PLN | -16.64% |
| 2018 FY | 17.72 Million PLN | -24.37% |
| 2018 Q4 | 17.72 Million PLN | -42.28% |
| 2018 Q1 | 22.5 Million PLN | -3.97% |
| 2018 Q2 | 21.03 Million PLN | -6.5% |
| 2018 Q3 | 30.7 Million PLN | 45.95% |
| 2017 Q4 | 23.43 Million PLN | -66.89% |
| 2017 Q2 | 27.03 Million PLN | -39.33% |
| 2017 Q1 | 44.55 Million PLN | -6.22% |
| 2017 FY | 23.43 Million PLN | -50.68% |
| 2017 Q3 | 70.77 Million PLN | 161.78% |
| 2016 Q3 | 53.77 Million PLN | -3.85% |
| 2016 Q1 | 61.68 Million PLN | -4.97% |
| 2016 FY | 47.5 Million PLN | -26.8% |
| 2016 Q2 | 55.93 Million PLN | -9.32% |
| 2016 Q4 | 47.5 Million PLN | -11.66% |
| 2015 Q1 | 91.7 Million PLN | -6.18% |
| 2015 FY | 64.9 Million PLN | -33.6% |
| 2015 Q4 | 64.9 Million PLN | -54.99% |
| 2015 Q3 | 144.21 Million PLN | 55.58% |
| 2015 Q2 | 92.69 Million PLN | 1.07% |
| 2014 Q3 | 85.28 Million PLN | -8.77% |
| 2014 Q4 | 97.75 Million PLN | 14.63% |
| 2014 Q2 | 93.48 Million PLN | -17.48% |
| 2014 FY | 97.75 Million PLN | -12.86% |
| 2014 Q1 | 113.28 Million PLN | 0.98% |
| 2013 Q3 | 134.45 Million PLN | 627.82% |
| 2013 Q4 | 112.18 Million PLN | -16.56% |
| 2013 FY | 112.18 Million PLN | 573.22% |
| 2013 Q1 | 15.96 Million PLN | -4.21% |
| 2013 Q2 | 18.47 Million PLN | 15.74% |
| 2012 Q3 | 21.66 Million PLN | -84.53% |
| 2012 Q1 | 138.92 Million PLN | 10.21% |
| 2012 Q4 | 16.66 Million PLN | -23.07% |
| 2012 FY | 16.66 Million PLN | -86.78% |
| 2012 Q2 | 140.02 Million PLN | 0.79% |
| 2011 Q3 | 122.34 Million PLN | 10.17% |
| 2011 Q4 | 126.05 Million PLN | 3.03% |
| 2011 FY | 126.05 Million PLN | 9.14% |
| 2011 Q1 | 112.07 Million PLN | -2.96% |
| 2011 Q2 | 111.05 Million PLN | -0.91% |
| 2010 Q2 | 20.03 Million PLN | 7.69% |
| 2010 Q1 | 18.6 Million PLN | -9.15% |
| 2010 FY | 115.49 Million PLN | 464.02% |
| 2010 Q4 | 115.49 Million PLN | 8.28% |
| 2010 Q3 | 106.66 Million PLN | 432.41% |
| 2009 Q4 | 20.47 Million PLN | 0.0% |
| 2009 FY | 20.47 Million PLN | -87.51% |
| 2008 FY | 163.89 Million PLN | 0.02% |
| 2007 FY | 163.86 Million PLN | 2050.22% |
| 2006 FY | 7.62 Million PLN | 20497.3% |
| 2005 FY | 37 Thousand PLN | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Bioceltix S.A. | 76.33 Thousand PLN | -16507.496% |
| Captor Therapeutics Spolka Akcyjna | 1.24 Million PLN | -916.6% |
| Mabion S.A. | 2.94 Million PLN | -330.02% |
| Molecure S.A. | 4.97 Million PLN | -154.772% |
| NanoGroup S.A. | - PLN | -Infinity% |
| Pharmena S.A. | 114 Thousand PLN | -11020.175% |
| Poltreg S.A. | 7.8 Million PLN | -62.505% |
| Pure Biologics Spólka Akcyjna | 12.85 Million PLN | 1.362% |
| Ryvu Therapeutics S.A. | 365 Thousand PLN | -3373.151% |
| Synthaverse S.A. | 61.2 Million PLN | 79.287% |
| Urteste S.A. | 312 Thousand PLN | -3963.141% |